Cargando…

Novel insights on targeting ferroptosis in cancer therapy

Ferroptosis belongs to a novel form of regulated cell death. It is characterized by iron dependence, destruction of intracellular redox balance and non-apoptosis. And cellular structure and molecules level changes also occur abnormally during ferroptosis. It has been proved that ferroptosis exist wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuo, Sipeng, Yu, Jie, Pan, Hui, Lu, Linna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532638/
https://www.ncbi.nlm.nih.gov/pubmed/33024562
http://dx.doi.org/10.1186/s40364-020-00229-w
_version_ 1783589967601074176
author Zuo, Sipeng
Yu, Jie
Pan, Hui
Lu, Linna
author_facet Zuo, Sipeng
Yu, Jie
Pan, Hui
Lu, Linna
author_sort Zuo, Sipeng
collection PubMed
description Ferroptosis belongs to a novel form of regulated cell death. It is characterized by iron dependence, destruction of intracellular redox balance and non-apoptosis. And cellular structure and molecules level changes also occur abnormally during ferroptosis. It has been proved that ferroptosis exist widespreadly in many diseases, such as heart disease, brain damage or alzheimer disease. At the same time, the role of ferroptosis in cancer cannot be underestimated. More and more indications have told that ferroptosis is becoming a powerful weapon against cancer. In addition, therapies rely on ferroptosis have been applied to the clinic. Therefore, it is necessary to understand this newly discovered form of cell death and its connection with cancer. This review summarizes the mechanism of ferroptosis, ferroptosis inducers based on different targets and inspection methods. At last, we analyzed the relationship between ferroptosis and malignancies, in order to provide a novel theory basis for cancer treatment.
format Online
Article
Text
id pubmed-7532638
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75326382020-10-05 Novel insights on targeting ferroptosis in cancer therapy Zuo, Sipeng Yu, Jie Pan, Hui Lu, Linna Biomark Res Review Ferroptosis belongs to a novel form of regulated cell death. It is characterized by iron dependence, destruction of intracellular redox balance and non-apoptosis. And cellular structure and molecules level changes also occur abnormally during ferroptosis. It has been proved that ferroptosis exist widespreadly in many diseases, such as heart disease, brain damage or alzheimer disease. At the same time, the role of ferroptosis in cancer cannot be underestimated. More and more indications have told that ferroptosis is becoming a powerful weapon against cancer. In addition, therapies rely on ferroptosis have been applied to the clinic. Therefore, it is necessary to understand this newly discovered form of cell death and its connection with cancer. This review summarizes the mechanism of ferroptosis, ferroptosis inducers based on different targets and inspection methods. At last, we analyzed the relationship between ferroptosis and malignancies, in order to provide a novel theory basis for cancer treatment. BioMed Central 2020-10-02 /pmc/articles/PMC7532638/ /pubmed/33024562 http://dx.doi.org/10.1186/s40364-020-00229-w Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Review
Zuo, Sipeng
Yu, Jie
Pan, Hui
Lu, Linna
Novel insights on targeting ferroptosis in cancer therapy
title Novel insights on targeting ferroptosis in cancer therapy
title_full Novel insights on targeting ferroptosis in cancer therapy
title_fullStr Novel insights on targeting ferroptosis in cancer therapy
title_full_unstemmed Novel insights on targeting ferroptosis in cancer therapy
title_short Novel insights on targeting ferroptosis in cancer therapy
title_sort novel insights on targeting ferroptosis in cancer therapy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532638/
https://www.ncbi.nlm.nih.gov/pubmed/33024562
http://dx.doi.org/10.1186/s40364-020-00229-w
work_keys_str_mv AT zuosipeng novelinsightsontargetingferroptosisincancertherapy
AT yujie novelinsightsontargetingferroptosisincancertherapy
AT panhui novelinsightsontargetingferroptosisincancertherapy
AT lulinna novelinsightsontargetingferroptosisincancertherapy